BRIDGEIDA ELHAZIN: Open Payments
NPI 1144252370 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 16 payments from 6 companies in 2025. Trend: 2023 $76 · 2024 $3,447 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $145 |
| Gilead Sciences, Inc. | 5 | $130 |
| Ipsen Biopharmaceuticals, Inc | 2 | $61 |
| Boston Scientific Corporation | 1 | $52 |
| Eton Pharmaceuticals, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: MAVYRET, TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial), Bylvay, IQIRVO, GALZIN, XIFAXAN.
Industry payments across CA — which companies pay providers there.
